Jove
Visualize
Contact Us

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

943
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
943
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

578
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Evaluation of Microbial Counts in GCF of Patients with Onlay- Retained Fixed Partial Denture Fabricated with Monolithic Zirconia and DMLS - An <i>Ex vivo</i> Study.

Journal of pharmacy & bioallied sciences·2026
Same author

Therapies and Pipeline for Hepatitis B and Hepatitis D.

Clinics in liver disease·2025
Same author

Artificial Intelligence and Machine Learning Applications in Liver Disease.

Clinics in liver disease·2025
Same author

Non-obstructive sinusoidal dilation in inflammatory bowel disease.

Clinics and research in hepatology and gastroenterology·2025
Same author

The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus.

Gastro hep advances·2024
Same author

A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies.

Gastro hep advances·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

661

Prognostic Models in Acute Liver Failure.

Avantika Mishra1, Vinod Rustgi2

  • 1Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson University Hospital, Medical Education Building, Room 478, One Robert Wood Johnson Place, New Brunswick, NJ 08901, USA.

Clinics in Liver Disease
|April 2, 2018
PubMed
Summary
This summary is machine-generated.

Developing accurate prognostic models for acute liver failure (ALF) is crucial. Current models need improvement to better predict patient outcomes, survival, and transplant needs, requiring enhanced statistical rigor.

Keywords:
Acute liver failureKing’s College CriteriaMELDModel for End-Stage Liver DiseasePrognostic models

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.1K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.2K

Related Experiment Videos

Last Updated: Feb 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

661
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.1K
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

13.2K

Area of Science:

  • Hepatology
  • Medical Statistics
  • Clinical Decision-Making

Background:

  • Acute liver failure (ALF) poses significant clinical challenges.
  • Existing prognostic models like King's College Criteria and MELD have limitations.
  • There is a critical need for improved predictive accuracy in ALF management.

Purpose of the Study:

  • To highlight the imperative for developing more accurate prognostic models for ALF.
  • To identify shortcomings in current clinical models for predicting ALF patient trajectories.
  • To outline requirements for future prognostic models in ALF.

Main Methods:

  • Review of existing prognostic models for acute liver failure.
  • Analysis of the need for enhanced statistical foundations in predictive modeling.
  • Consideration of time-dependent factors and clinical variability in ALF.

Main Results:

  • Current prognostic models, including King's College Criteria and MELD, require significant improvement.
  • Existing models inadequately capture the dynamic nature of ALF.
  • Enhanced statistical approaches are necessary for better patient outcome prediction.

Conclusions:

  • Future prognostic models for ALF must incorporate stronger statistical methodologies.
  • Models need to account for the time-varying nature and variability of ALF.
  • Improved models are essential for both pretransplant and posttransplant decision-making in ALF.